Skip Navigation
Print Page

Staff Detail

Skip sharing on social media links
Share this:

Zilbermint, MIHAIL

Formal Title:



Dr. Zilbermint specializes in the diagnosis and treatment of metabolic and endocrine-related conditions.





10 CENTER DR Room 1-3216, MSC 1103
Bethesda Md 20892-1103
For FedEx use:
Bethesda Md 20892


Dr. Zilbermint is a board-certified Endocrinologist. He received his medical degree from the State Medical and Pharmaceutical University N. Testemitanu, Moldova. He completed his Internal Medicine training at Saint Agnes Hospital, Baltimore, MD. Zilbermint joined the Endocrinology Fellowship at National Institute of Health in July 2012.

During his work at the Section on Endocrinology and Genetics, NICHD, he developed a particular interest in rare genetic diseases. He was the first to describe and publish the clinical phenotype of the NIH cohort of patients with novel mutations in ARMC5 gene, which can cause macronodular adrenal hyperplasia and Cushing’s syndrome. Zilbermint was invited to share this discovery as an oral presentation at the International Congress of Endocrinology/ Endocrine Society’s 96th Annual Meeting in Chicago, IL in June 2014. He is currently interested in exploring whether the ARMC5 gene plays a role in other endocrinopathies.

Dr. Zilbermint is an associate clinical investigator in the following NIH clinical research studies: “A Clinical and Genetic Investigation of Pituitary Tumors and Related Hypothalamic Disorders”, “Clinical and Molecular Analysis of ACTH-Independent Steroid Hormone Production in Adrenocortical Tissue”, and “Evaluation of Patients with Endocrine-Related Conditions”.

Dr. Zilbermint received awards and grants from European Society of Endocrinology, International Society of Endocrinology and Endocrine Society. He is an active volunteer at a camp for children with type I diabetes.


Publications (PubMed):

Title Authors Publication Date
Macronodular adrenal hyperplasia due to mutations in an armadillo repeat containing 5 (ARMC5) gene: a clinical and genetic investigation.Faucz FR,Zilbermint M,Lodish MB,Szarek E,Trivellin G,Sinaii N,Berthon A,Libé R,Assié G,Espiard S,Drougat L,Ragazzon B,Bertherat J,Stratakis CAJ Clin Endocrinol Metab2014 Jun
A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical 'salt bridge' Kir3.4 residue.Monticone S,Bandulik S,Stindl J,Zilbermint M,Dedov I,Mulatero P,Allgaeuer M,Richard Lee CC,Stratakis CA,Ann Williams T,Tiulpakov AJ Clin Endocrinol Metab2014 Oct 16
Death in pediatric Cushing syndrome is uncommon but still occurs.Gkourogianni A,Lodish MB,Zilbermint M,Lyssikatos C,Belyavskaya E,Keil MF,Stratakis CAEur J Pediatr2014 Sep 23
Pituitary stalk lesion in a 13-year-old female.Zilbermint M,Ramnitz MS,Lodish MB,Kanaka-Gantenbein C,Kattamis A,Lyssikatos C,Patronas NJ,Quezado MM,Stratakis CAJ Pediatr Endocrinol Metab2014 Mar
Relationship between sex hormones and cognitive performance in men with substance use.Zilbermint MF,Wisniewski AB,Xu X,Selnes OA,Dobs ASDrug Alcohol Depend2013 Mar 1
Nonsteroidal selective androgen receptor modulator Ostarine in cancer cachexia.Zilbermint MF,Dobs ASFuture Oncol2009 Oct
Vision National Institutes of Health Home BOND National Institues of Health Home Home Storz Lab: Section on Environmental Gene Regulation Home Machner Lab: Unit on Microbial Pathogenesis Home Division of Intramural Population Health Research Home Bonifacino Lab: Section on Intracellular Protein Trafficking Home Lilly Lab: Section on Gamete Development Home Lippincott-Schwartz Lab: Section on Organelle Biology